Product: Lenstar Myopia from Haag Streit.
Top Line: The Haag Streit Lenstar Myopia now includes the new AMMC (Age-Matched Myopia Control) framework by Prof. Dr. Hakan Kaymak. This first-of-its-kind framework will provide diagnostic support based on the eye’s axial growth.
Close Up: Lenstar Myopia is a comprehensive solution for myopia management; it enables the eye care professional to obtain fast, precise measurements and quickly and confidently interpret data to detect myopia. The new AMMC framework provides excellent data on the eye's expected length growth considering age, gender, and sociocultural environment. The eye care professional can compare axial length growth speed to a broad demographic database. Pathologically fast eye growth can be rapidly identified using an easy-to-understand traffic light system.
Vital Stats: Haag-Streit’s new AMMC framework was designed to set a therapy goal for myopia management. AMMC allows the eye care professional to observe and assess axial length growth over time and overlay potential treatments. This makes it possible to understand therapy effectiveness rapidly, allowing the eye care professional to adjust the individual patient's therapy, as required, continuously. AMMC employs a simple traffic light system to judge the current efficiency of the therapy. The therapy is highly efficient if the assessed eye growth rate is located in the “green field” of the AMMC scheme. AMMC, also gives the percentage of how much the actual axial eye growth of the patient is in excess of the normative physiological growth. So, even if a patient’s eye remains in the “red field” in the initial treatment periods, the practitioner might still be able to communicate a first therapeutic success based on these percentage numbers.
www.haag-streit.com